Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs Beckman Coulter Sample Press Release

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs; Expands Reach for Ortho and Broadens Menu for Beckman Coulter    BREA, CA, and RARITAN, NJ, June 8, 2016 — Beckman Coulter, Inc., a global developer and manufacturer of clinical diagnostic products, and Ortho Clinical Diagnostics (Ortho), a global in vitro diagnostics... Read more

Beckman Coulter Features Prostate Health Index (phi) at 2016 AUA Annual Meeting

PROSTATE HEALTH INDEX (phi) BLOOD TEST GIVES YOU MORE CONFIDENCE BEFORE BIOPSY, REDUCING UNNECESSARY BIOPSIES BY 30%   BREA, CALIF. — (May 6, 2016) — Beckman Coulter Diagnostics, a leader in prostate cancer testing, will demonstrate its dedication to advancing healthcare for patients and physicians at the 2016 American Urological Association (AUA) Annual Meeting in... Read more

New Access TSH (3rd IS) Assay Released with CE Mark for Use on the Beckman Coulter Access Family of Immunoassay Systems

  NYON, SWITZERLAND – (January 21, 2016) – Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. This new assay is the next generation of the Access HYPERsensitive hTSH and Access Fast hTSH... Read more

Leading Cancer Research Lab Announced as Winner in Beckman Coulter’s $…

Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields   Forgot your password? Please provide the email address and your last name associated... Read more

Beckman Coulter Diagnostics Receives 2015 Scientists’ Choice Award for Best New Clinical Laboratory Product

Access Anti-Müllerian Hormone (AMH) Assay Voted Best New Clinical Product of 2014   BREA, CALIF. – (August 31, 2015)  – Beckman Coulter Diagnostics’ automated Access Anti-Müllerian Hormone (AMH) assay* was recently selected as the Best New Clinical Laboratory Product of 2014 for the 2015 Scientists’ Choice Award by members of SelectScience®. The award was presented... Read more

Beckman Coulter Diagnostics and COPAN Announce Expansion of Distributi…

Beckman Coulter Diagnostics and COPAN, a company committed to innovation in the field of pre-analytics, recently announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab... Read more

Beckman Coulter Diagnostics Demonstrates Solutions to Balance Better C…

Standardized Processes and Improved Operational Efficiency Move Healthcare Forward   BREA, CALIF. — (July 24, 2015) — Beckman Coulter Diagnostics will be showcasing its comprehensive portfolio of high-productivity analytical and workflow systems at the 2015 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga., July 28-30, 2015. Clinical Lab... Read more